TRCT
CDAK

Tower Research Capital (TRC)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Tower Research Capital (TRC)’s Portfolio CDAK Stock Details CDAK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$1K Sell
2022
Q4 		$10K Buy
2022
Q3 		$5K Buy
2022
Q2 		$8K Buy
2022
Q1 		$10K Sell
2021
Q4 		$28K Buy
2021
Q3 		$10K Sell
2021
Q2 		$18K Buy
2021
Q1 		$13K Buy
2020
Q4 		$17K Buy